Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,373 total articles
Astrana Health (ASTH) runs a delegated-risk, physician-centric population health platform that has delivered strong top-line growth and free cash flow. Shares trade near $28 with an EV/sales of ~0.68 and a free cash flow of $104.5M — attractive for a revenue-growing, risk-bearing operator. We lay out a mid-term (45 trading days) long trade with def…
Granite Construction has rebuilt margins, locked in materials integration benefits and sits squarely in the path of renewed public infrastructure spending. Technical momentum, improving fundamentals and manageable leverage support a mid-term long trade with a clear risk/reward.
Par Pacific has turned into a compact, high-return refining-and-logistics play: robust free cash flow, sub-1x EV/sales, and double-digit ROE. With refining crack spreads elevated and operational throughput strong, the stock looks actionable from current levels. I outline an entry, stop, and target for a long trade and the catalysts and risks that m…
Aehr Test Systems (AEHR) is surfacing as a niche but critical provider of wafer-level test and burn-in systems for AI data-center components. Recent orders for silicon photonics and AI processor customers have re-rated the stock. I recommend a tactical long swing with a $62 entry, $85 target and $48 stop, horizon ~45 trading days, betting on follow…
Lucid (LCID) is trading near its 52-week low after headline-driven selling and heavy short interest. Production and supplier snags have weighed on margins, but the market already prices in poor near-term unit economics. With a market cap of roughly $2.95B, heavy short positioning and improving technicals, this is a tactical long trade for traders w…
Oracle has quietly built an AI infrastructure business that combines software, purpose-built hardware, and deep enterprise relationships. While markets focus on hyperscalers and chip makers, Oracle's OCI + Exadata stack offers a lower-cost, easier-to-deploy route for enterprise GenAI. This trade idea buys the gap between perception and reality with…
Red Cat recently closed strategic M&A, landed institutional orders and signed cross-border partnerships that materially improve its product mix and addressable market. The balance sheet is clean and revenue is accelerating, yet the stock still shows momentum slack and macro-driven dips. This trade idea lays out a mid-term long with defined entry, s…
AutoZone's business combines high margins, strong cash generation, and a resilient mix of DIY and commercial customers. Near-term uncertainty has pressured sentiment and presented a defined risk-reward entry. We upgrade to Buy and lay out a specific trade plan with clear entry, target, and stop-loss levels.
AbbVie combines a 3.2% yield, industry-leading free cash flow and a growing immunology franchise that replaced Humira. The stock is digesting gains and trading near technical support; a disciplined long trade with tight risk control offers asymmetric reward if Skyrizi/Rinvoq execution and margin recovery persist.
Wingstop's share price has retraced aggressively from its 2025 highs after same-store sales went negative. At ~$174.88 the market has priced in a prolonged traffic problem; it has not fully priced in a plausible recovery and continued asset-light expansion. This trade idea lays out an entry at $174.88, a $220 target, and a $150 stop for a mid-term …
Armanino Foods has the product portfolio and recent top-line momentum to justify a tactical long. The valuation is modest in absolute terms - market cap ~$331M and P/E ~17 - but liquidity, OTC listing and execution risk keep this from being a buy-and-hold. Enter at $10.40 with a $12.25 target and $9.20 stop for a mid-term (45 trading days) swing th…
Hims & Hers ($19.95) has been painted as a busted partnership story and a cybersecurity casualty, but the underlying business still generates free cash flow, has positive ROE and a path to monetize weight-loss services. The trade idea: buy into consolidation around $19.95, target $26.00 in ~45 trading days, stop at $17.00. This is a mid-term, measu…
Becton Dickinson (BDX) trades at a reasonable multiple with steady free cash flow, a healthy dividend, and an underappreciated optionality: the company’s portfolio tilt toward higher‑value devices and diagnostics makes a break-up or strategic carve‑out a plausible catalyst. This trade targets that re‑rating with defined entry, stop and target level…
Kinder Morgan's recent run higher is rooted in fundamentals — steady pipeline volumes, predictable fee-based cash flow, and visible capital allocation that favors shareholders. This trade idea lays out a disciplined entry at $25.00, a stop at $22.00, and a target at $30.00 over a 180-trading-day horizon, with clear risks and catalysts to monitor.
Tesla is richly valued, technically weak, and politically visible. Still, $TSLA's combination of positive free cash flow, negligible net debt, strong liquidity ratios, and company-specific catalysts argue against a sudden collapse. This trade idea lays out an entry, stop, target, time horizon, and the risks that would change the stance.
Advantage Energy (AAVVF) looks actionable on a mid-term recovery trade keyed to the resumption of production at Glacier. The shares trade at a $1.37B market cap, a sub-1.0 PB multiple and an RSI near 30, creating a favorable risk/reward if Glacier ramps on schedule. This plan lays out entry, stop and targets for a 45-trading-day swing and the key r…
Snap is trading like a broken growth story but still generates meaningful free cash flow and trades at a sub-$9B market cap. The balance sheet strain, persistent losses and regulatory/legal overhang make restructuring increasingly likely. That risk, priced in, creates an entry that underwrites downside with a defined stop and targets a 21% return i…
Telix reported Q1 2026 revenue of $230M (up 11% QoQ) and reaffirmed FY26 guidance of $950-970M. Positive clinical readouts and a resubmitted NDA for TLX101-Px give the stock a fundamental bid. Technicals are constructive and short activity is elevated, creating asymmetric upside for a controlled swing trade.
Blue Owl Capital faces three compounding headwinds: fund-level liquidity constraints after redemption caps, rising private-credit underwriting stress tied to software exposure, and a dividend/valuation mismatch that limits upside. Technicals and increased short activity favor a mid-term short. Trade plan: short at $8.77, stop $10.60, target $5.50, …
Credo Technology is a high-margin supplier of high-speed connectivity (AECs, SerDes chiplets) that reported 201% YoY revenue growth and 68.5% gross margins in its most recent quarter. With a roughly $20.7B market cap, clean balance sheet and product roadmap aimed at the 800GB-1.6TB GPU upgrade cycle, the stock offers an asymmetric risk/reward for a…
Amazon appears positioned to capture a new leg of AI infrastructure spending as customers move from prototype to production. Strong partner news, improving revenue-per-employee and bullish price momentum support a tactical long trade: entry $222.70, target $270.00, stop $204.00 for a 45-trading-day swing.
Broadcom (AVGO) is uniquely positioned to capture the next wave of AI infrastructure spend driven by large foundational model deployments and appliance rollouts from players like Anthropic. This trade idea recommends a tactical long with a disciplined stop and a multi-month horizon to let enterprise adoption and data-center upgrades play out.
Moody's ($MCO) combines high free cash flow, a compact share count and repeated shareholder returns. With technicals showing constructive momentum and short interest low on days-to-cover, buybacks are likely establishing a near-term floor. This trade idea lays out an actionable long with entry, stop and targets across a 45- to 180-trading-day horiz…
Caterpillar is uniquely positioned to benefit from the 'gigawatt pivot' as hyperscalers and industrial players scramble for reliable, on-site power. With a $337B market cap, $7.45B in free cash flow and a healthy backlog tied to power projects, the risk/reward favors a mid-term long. Trade plan: enter $745.00, stop $710.00, target $820.00, horizon …
Recent headlines around the Galleri NHS readout dented sentiment for Illumina, but the company's underlying fundamentals - $19.3B market cap, $931M free cash flow and 31% ROE - argue for a recovery. This is a long trade on weakness: enter $126.44, target $155.00, stop $116.00 with a 180-trading-day horizon.
